课题基金 / 基金详情

Epidemiology of Age-related Macular Degeneration and Other Retinal Diseases - Enrollment Center

Epidemiology of Age-related Macular Degeneration and Other Retinal Diseases - Enrollment Center
年龄相关性黄斑变性和其他视网膜疾病的流行病学 - 招生中心
批准号:
8852941
负责人:
BARBARA EDEN KLEIN
金额:
$38.96万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

BARBARA EDEN KLEIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Epidemiology of Age-Related Macular Degeneration and Other Retinal Diseases Project Summary/Abstract This proposal builds on a longitudinal cohort study of persons participating in the Beaver Dam Eye Study (BDES), funded by National Eye Institute grant U10 EY006594. The study included persons aged 43-86 years living in the city and township of Beaver Dam, Wisconsin who were identified in a private census in 1987- 88 and were examined in 1988-1990 and every 5 years thereafter. At each examination, age-related macular degeneration (AMD) and other retinal diseases were graded from stereoscopic fundus photography, and refraction and visual acuity were measured. This will be done at the 25 year follow-up. Spectral domain optical coherence tomography (SD-OCT), a noninvasive, quantitative method used to measure retinal thickness and to document other anatomic features not observed with fundus photography, and frequency doubling technology (FDT) perimetry were added at the 20-year follow-up. We will measure skin intrinsic fluorescence (SIF), serum advanced glycation endproducts (AGEs), a soluble receptor for AGEs (s-RAGE), and oxidized low-density lipoprotein cholesterol (ox-LDL), a marker of oxidative stress, at the proposed 25-year follow-up examination. In addition, we will measure AGEs and ox-LDL from frozen serum collected at previous examinations to determine their longitudinal associations to the incidence and progression of AMD over the 25 years of study, as well as how markers of inflammation, subclinical atherosclerosis and candidate genes may alter the associations. We will examine the utility of these measures for risk assessment of developing AMD. We will also examine the relationships of SIF with the prevalence and severity of AMD, the relationships of retinal morphology identified by SD-OCT and FDT perimetry to the 5-year incidence and progression of AMD as measured by color fundus photographs, and the longitudinal relationships of the aforementioned newly measured analytes to retinopathy and cataract. Discovering and describing retinal features that are harbingers of the development of the earliest lesions of AMD through SD-OCT will permit timely intervention to derail or prevent the development of AMD. The new data from this study will provide a unique opportunity to examine the role of nonenzymatic glycation and oxidative stress in the pathogenesis of AMD independent of age, smoking status, and high-risk genetic markers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epidemiology of Retinopathy and other Complications in Long Term Type 1 Diabetes
  • 批准号:
    9045636
  • 项目类别:
  • 资助金额:
    $52.73万
  • 财政年份:
    2005
  • 负责人:
    BARBARA EDEN KLEIN
  • 依托单位:
Epidemiology of Retinopathy and other Complications in Long Term Type 1 Diabetes
  • 批准号:
    8294242
  • 项目类别:
  • 资助金额:
    $154.39万
  • 财政年份:
    2005
  • 负责人:
    BARBARA EDEN KLEIN
  • 依托单位:
Linkage Studies of Quantitative Ocular Traits
  • 批准号:
    6916652
  • 项目类别:
  • 资助金额:
    $24.65万
  • 财政年份:
    2005
  • 负责人:
    BARBARA EDEN KLEIN
  • 依托单位:
Epidemiology of Retinopathy and other Complications in Long Term Type 1 Diabetes
  • 批准号:
    8461555
  • 项目类别:
  • 资助金额:
    $134.99万
  • 财政年份:
    2005
  • 负责人:
    BARBARA EDEN KLEIN
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: